Inductively coupled plasma optical emission spectroscopy (ICP-OES, also known as ICP-AES) works by introducing a prepared sample into a high-temperature argon plasma, where elements are atomized and excited, then identified and quantified by measuring their characteristic optical emission wavelengths. For pharmaceutical researchers, analytical development scientists, formulation teams, materials specialists, and CRO partners, ICP-OES testing helps answer practical questions: which elements are present, at what levels are catalyst residues or trace metals observed, how do raw materials differ by supplier or batch, and whether a formulation matrix introduces unexpected inorganic signals? BOC Sciences provides customized ICP-OES testing services for APIs, intermediates, excipients, formulations, process samples, raw materials, packaging-contact extracts, biomaterials, and specialty chemicals. With integrated element analysis capabilities, our team delivers clear, data-driven elemental profiles that support confident material selection, process troubleshooting, and development-stage decision-making.
BOC Sciences provides ICP-OES-based elemental quantitative analysis for solid, liquid, powder, extract, solution, and process-related samples. The service is designed to determine selected metals and inorganic elements with suitable sample preparation, calibration design, wavelength selection, and matrix review.
ICP-OES is well suited for simultaneous multi-element screening when clients need a broad view of elemental composition rather than a single-element result. BOC Sciences develops screening panels according to sample type, suspected sources, matrix background, and the decision the client needs to make.
For projects focused on one critical element, BOC Sciences provides single-element in-depth ICP-OES analysis with enhanced attention to wavelength selection, calibration behavior, matrix effects, dilution strategy, and potential spectral interference. This approach is useful when one element drives material performance, impurity investigation, process control, or troubleshooting decisions.
When total elemental content cannot explain sample behavior, BOC Sciences supports speciation analysis by coupling ICP-OES with suitable separation or fractionation techniques. This service helps distinguish different chemical forms of the same element, including ionic, complexed, organometallic, soluble, particulate, or matrix-bound species.
BOC Sciences helps clients move from uncertain metal signals to clear ICP-OES results by integrating sample preparation, wavelength selection, calibration strategy, interference review, and development-focused interpretation.
We measure multiple elements in a single analytical run, supporting targeted panels, exploratory elemental profiling, material comparison, catalyst residue monitoring, and formulation-related metal assessment.
Depending on concentration range and matrix load, we select suitable plasma viewing conditions to balance sensitivity, matrix tolerance, signal stability, and reliable quantification.
Our analysts evaluate emission lines, background regions, spectral overlaps, matrix elements, and alternative wavelengths to reduce false positives and improve confidence in reported values.
We apply sample-specific preparation approaches for powders, liquids, polymers, oils, salts, extracts, and high-solid matrices, aiming for homogeneous solutions suitable for ICP-OES introduction.
We design calibration ranges, blank controls, check solutions, dilution schemes, and replicate measurements according to concentration expectations and the client's decision-making requirements.
ICP-OES can be combined with complementary methods through BOC Sciences' analytical platform to connect elemental data with molecular, material, and formulation evidence.
We provide flexible ICP-OES testing for pharmaceutical, biotechnology, chemical, material, and packaging-contact samples. Our scientists adapt preparation chemistry, dilution factor, calibration range, wavelength selection, and reporting format so that each result directly addresses the client's scientific question.
Share your sample type, target elements, expected concentration range, matrix composition, solvent system, available sample amount, and comparison groups. Our specialists will design a project-specific method development plan for reliable ICP-OES testing and interpretation.
We review the analytical goal, sample matrix, target elements, expected concentration range, sample amount, digestion feasibility, dilution needs, potential interferences, and comparison groups to determine whether the study should focus on targeted quantification, broad elemental screening, catalyst residue tracking, raw material comparison, extract analysis, or troubleshooting.
We define digestion chemistry, dilution scheme, solvent compatibility, calibration range, internal correction, rinse protocol, emission wavelength selection, replicate strategy, and interference review. For difficult matrices, we optimize sample introduction and plasma conditions to reduce memory effects, high-solid loading, viscosity-related instability, and matrix-driven signal bias.
We acquire ICP-OES emission data using selected wavelengths, calibration solutions, blanks, check samples, prepared test solutions, and replicate measurements. Signal intensity, background correction, dilution factors, and spectral behavior are reviewed so that each reported concentration can be traced to the corresponding sample preparation and acquisition conditions.
Our team reviews calibration performance, blank contribution, replicate consistency, potential spectral interference, matrix behavior, and sample-to-sample differences. The final report can include concentration tables, dilution details, element panels, comparative summaries, method notes, and concise conclusions linked to material selection, formulation development, or process troubleshooting decisions.
APIs, excipients, polymers, lipid systems, coated particles, and high-mineral formulations can behave very differently during dissolution or digestion. BOC Sciences addresses this by selecting matrix-appropriate acid systems, controlled digestion conditions, dilution factors, and preparation blanks. When complete digestion is difficult, we design comparative extraction or partial-digestion approaches that still answer the client's development question.
ICP-OES spectra may include overlapping emission lines, high background, easily ionized element effects, and matrix-driven signal shifts. Our analysts compare alternative wavelengths, evaluate background correction regions, review expected chemistry, and check whether neighboring elements could influence the signal. When needed, BOC Sciences can recommend complementary approaches such as AAS testing, X-ray fluorescence testing, or ion chromatography testing.
One sample may contain sodium, potassium, calcium, or magnesium at relatively high levels while transition metals or catalyst residues appear near trace levels. We manage this by designing appropriate dilution strategies, calibration ranges, wavelength choices, and re-analysis plans for selected elements, avoiding a one-size-fits-all method that misses low-level signals or saturates high-level elements.
Clients often need more than a table of elemental concentrations. They need to know whether a metal is formulation-derived, process-related, supplier-specific, packaging-associated, or linked to a visible residue. BOC Sciences integrates ICP-OES results with sample history, preparation notes, comparison groups, and complementary impurities identification and characterization strategies to support next-step experimental planning.
Collaborate with BOC Sciences to design ICP-OES studies that reveal elemental composition, trace metal patterns, catalyst residues, formulation-related inorganic signals, extract profiles, and sample-to-sample differences with clear, decision-ready interpretation.
BOC Sciences understands that pharmaceutical clients need actionable interpretation rather than isolated elemental values. We connect ICP-OES results with sample matrix, formulation composition, process history, and comparison objectives to explain what the elemental profile means for development-stage decisions.
Our ICP-OES workflows are adapted to the sample rather than forced into a fixed protocol. We optimize digestion, dilution, solvent compatibility, calibration design, rinse procedures, wavelength selection, and interference review for powders, liquids, polymers, extracts, oils, salts, and complex formulations.
When elemental data require broader confirmation, BOC Sciences can integrate complementary analytical technologies, spectroscopy, chromatography, mass-based testing, material characterization, and formulation analysis to build a more complete understanding of the sample.
We provide element concentration tables, preparation details, calibration notes, comparative summaries, and concise conclusions so analytical scientists, formulation teams, project managers, and CRO partners can quickly understand the evidence and plan the next experiment.
Client Needs: A medicinal chemistry group needed to quantify Pd, Ni, Cu, and Fe in a late-stage API intermediate after a metal-catalyzed coupling and several purification modifications.
Challenges: The intermediate showed limited aqueous solubility, and the expected metal levels differed substantially across elements. The client needed a method that could compare purification conditions without over-diluting low-level catalyst residues.
Solution: We screened acid digestion and organic dilution routes, then selected a mixed-acid digestion compatible with the intermediate. ICP-OES acquisition used separate calibration ranges for high- and low-response elements, with alternative emission lines reviewed for Pd and Fe. Across 24 process samples, we generated replicate concentration tables and purification-step trend summaries for the client.
Outcome: The study identified one purification condition that consistently reduced Pd and Ni while maintaining acceptable recovery of the target intermediate for the client's next synthesis campaign.
Client Needs: A formulation team developing lipid-based prototypes needed to compare Na, K, Ca, Mg, Zn, and Fe levels across excipient sources and three formulation compositions.
Challenges: The lipid matrix produced unstable nebulization after simple dilution, while calcium and magnesium appeared at much higher levels than the transition metals of interest. A single dilution could not cover all analytes reliably.
Solution: Our team evaluated solvent-assisted dispersion followed by controlled acid digestion, then created two dilution levels for major and trace elements. ICP-OES runs included matrix-matched calibration checks, extended rinse cycles, and duplicate digestions for representative lots. We analyzed 18 formulation and excipient samples, producing element-by-source and element-by-prototype comparison tables.
Outcome: The results showed that one excipient source contributed most of the calcium signal, helping the client refine supplier selection and prioritize a lower-background prototype.
Client Needs: A device-materials group observed a faint residue after storing a buffer formulation in contact with polymer components and needed to determine whether the residue was associated with elemental leaching.
Challenges: The extract contained low dissolved solids, but the residue was sporadic and visually subtle. The client needed comparison across blank extracts, contact extracts, and residue-enriched fractions.
Solution: We prepared matched blanks, contact extracts, and residue-enriched fractions using acid-stabilized dilution. ICP-OES analysis targeted Al, Ca, Mg, Si, Zn, Ti, and Fe with wavelength confirmation for elements suspected from the polymer formulation. Twelve extract sets were analyzed in duplicate, and results were summarized by contact condition, residue presence, and material lot.
Outcome: The elemental profile indicated elevated Si and Ca in residue-enriched fractions, guiding the client toward focused review of polymer additives and contact-surface processing conditions.
ICP-OES Testing, or inductively coupled plasma optical emission spectroscopy testing, is an elemental analysis technique used to determine the content of metals and selected non-metal elements in a sample. Its principle is based on introducing a nebulized sample aerosol into a high-temperature argon plasma, where atoms or ions are excited by the plasma energy. When these excited species return to lower energy states, they emit light at characteristic wavelengths. The instrument measures the intensity of these emission lines to identify and quantify elements. ICP-OES is well suited for simultaneous multi-element analysis and is widely used in pharmaceuticals, chemicals, materials, catalysts, environmental samples, and personal care formulations.
In drug development, ICP-OES can be used to analyze elemental information in APIs, intermediates, excipients, formulation samples, and process-related materials. For example, metal catalysts used in organic synthesis, inorganic salt residues, metal-containing coordination compounds, and metallic components in nanomedicine carriers can be evaluated by ICP-OES for quantitative or semi-quantitative purposes. For research teams, the value of ICP-OES is not limited to obtaining elemental concentration data. It also helps determine whether a synthetic route, purification process, excipient selection, or formulation condition may introduce specific elements, providing useful analytical evidence for formulation optimization and process adjustment.
ICP-OES is suitable for detecting a wide range of metallic elements and some non-metal elements, including lithium, sodium, magnesium, aluminum, potassium, calcium, titanium, chromium, manganese, iron, cobalt, nickel, copper, zinc, cadmium, lead, and other commonly analyzed elements. It is especially useful for samples requiring simultaneous multi-element analysis, such as metal catalyst systems, inorganic materials, polymer fillers, nanoparticles, ceramic powders, pharmaceutical synthesis samples, and personal care formulations. Because each element has different emission wavelengths, sensitivity, and potential spectral interferences, method conditions are usually selected according to target elements, sample matrix, and expected concentration range.
ICP-OES typically requires samples to be introduced into the plasma as stable, homogeneous, and nebulizable liquid solutions. Therefore, solids, powders, polymers, oils, complex formulations, and inorganic materials often require sample preparation such as acid digestion, dilution, extraction, or dissolution. The main purpose of sample preparation is to fully release target elements into solution while reducing matrix effects on nebulization, plasma stability, and optical detection. Incomplete preparation may cause poor element recovery, precipitation, particle blockage, matrix suppression, or spectral interference. As a result, sample preparation design has a direct influence on the reliability and interpretability of ICP-OES data.
ICP-OES and ICP-MS both use inductively coupled plasma as a high-energy source, but their detection principles are different. ICP-OES measures the characteristic optical emission produced when excited elements release energy, making it suitable for multi-element analysis, medium-to-high concentration measurements, and routine elemental composition studies in complex matrices. ICP-MS measures ions according to their mass-to-charge ratio and usually provides higher sensitivity, making it more suitable for ultra-trace elemental analysis. For pharmaceutical, materials, and chemical development projects, the choice between ICP-OES and ICP-MS depends on the target elements, concentration levels, sample matrix, analytical objective, and required data depth. BOC Sciences can design an appropriate elemental analysis strategy based on sample characteristics and project goals.
We needed more than a basic metal table. BOC Sciences helped us compare catalyst residues across purification conditions and explained which signals were method-related versus process-related.
— Hansen, Senior Analytical Scientist
Our lipid formulation was difficult to prepare consistently, but their team adjusted digestion and dilution strategy carefully. The final ICP-OES report gave us useful supplier and prototype comparisons.
— Koch, Formulation Development Lead
BOC Sciences helped us understand whether a visible residue was linked to elemental enrichment. The comparison between blanks, extracts, and residue fractions was clear and directly useful for our investigation.
— Wolf, Materials Characterization Manager
Their scientists asked the right questions about target elements, matrix composition, and expected concentration range. The ICP-OES workflow was tailored to our samples rather than treated as a generic test.
— Larsen, Drug Development Project Scientist
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
